Company Name or Ticker Symbol
Search for other Categories

Tesaro, Inc.  (TSRO)
Other Ticker:  
    Sector  Healthcare    Industry Major Pharmaceutical Preparations

TSRO's Revenue Year on Year Growth by Quarter and Year

Tesaro,'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
TSRO Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December 4.23 0.23 - -
III Quarter September 3.73 0.09 - -
II Quarter June 36.56 - - -
I Quarter March 0.31 - - -
FY   44.83 0.32 - -

Financial Statements
Tesaro,'s forth quarter 2016 Revenue $ 4.23 millions TSRO's Income Statement
Tesaro,'s forth quarter 2015 Revenue $ 0.23 millions Quarterly TSRO's Income Statement
TSRO's Growth by Division See TSRO's Growth by Segment

TSRO Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December 1736.96 % - - -
III Quarter September 4044.44 % - - -
II Quarter June - - - -
I Quarter March - - - -
FY   13907.81 % - - -

TSRO Revenue Growth Comment
Tesaro, Inc. reported Revenue surge of 1736.96% year on year in the forth quarter, to $ 4.23 millions, this is lower than Tesaro, Inc.'s recent average Revenue surge of 2962.16%.
This represents worst decline in recent Company history.

Looking into forth quarter results within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Revenue growth. While Tesaro, Inc.' s Revenue doubling of 1736.96% ranks overall at the positon no. 31 in the forth quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #3
Healthcare Sector #6
S&P 500 #31
Revenue Y/Y Growth Statistics
High Average Low
4187.36 % 2962.16 % 1736.96 %
(Sep 30 2016)   (Dec 31 2016)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TSRO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for TSRO's Competitors
Revenue Growth for Tesaro,'s Suppliers
Revenue Growth for TSRO's Customers

You may also want to know
TSRO's Annual Growth Rates TSRO's Profitability Ratios TSRO's Asset Turnover Ratio TSRO's Dividend Growth
TSRO's Roe TSRO's Valuation Ratios TSRO's Financial Strength Ratios TSRO's Dividend Payout Ratio
TSRO's Roa TSRO's Inventory Turnover Ratio TSRO's Growth Rates TSRO's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2016
Tesaro, Inc.  1,736.96 %$ 1,736.957 millions
Boston Therapeutics, Inc.  1,308.87 %$ 1,308.872 millions
Guided Therapeutics Inc  1,222.22 %$ 1,222.222 millions
Psivida Corp.  1,035.17 %$ 1,035.171 millions
Arena Pharmaceuticals Inc  1,001.46 %$ 1,001.458 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
MON's Profile
Stock Price
MON's Financials
MON's Expectations
Business Description
Charts & Quotes
MON's News
MON's Competitors
Customers & Markets
Economic Indicators
MON's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com